Hematology Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

  • To Be Published : Nov 2019 |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Hematology is a branch of medicine that involves the study of blood in health and diseases. Individuals may get affected by several blood-related diseases such as blood cancer, anemia, bleeding disorders that include hemophilia, blood clots, and some others. Hematology includes the problems with the red blood cells, white blood cells, platelets, bone marrow, spleen, lymph nodes, blood vessels, and proteins involved in the clotting and bleeding. A Hematologist is a medical doctor who deals with the diagnosis, treatment, and overall management of individuals with blood disorders. The specialists use the hematology instruments for testing, counting, analyzing and measuring red blood cells, platelets, and white blood cells. These instruments are used for regular and critical testing in clinical laboratories, and further helps to provide the solution to physicians and healthcare providers.

Growing population with blood-related disorders globally is driving the hematology market

According to data given by Leukemia and Lymphoma society (LLS) in 2015, around 9.8% of the population in the United States was diagnosed with leukemia, lymphoma, and myeloma. The data given by National Hemophilia Foundation shows that approximately 400,000 people are suffering from hemophilia in U.S. Growing population with blood-related disorders is the major factor driving the growth of the hematology market.

The hematology instruments are showing the transition from traditional instruments to semi-automated instruments and to the recent automated instruments. For instance, Beckman Coulter’s automatic hematology analyzer Unicel DxH slidemaker strainer cellular analysis system has a ‘load and go’ feature that provides the most advanced slide making technology. This analyzer is supported by DxH SMS software that is helping to increase the productivity of diagnostic laboratories. The adoption of these automated instruments by diagnostic laboratories is also owing to the growth of the hematology market. Additionally, some advancements in the research areas such as genetic therapies, stem cell research, proteomics, pharmacogenomics, and bleeding disorders, is another factor contributing to the progress of the hematology market.

 However, the high cost of hematology instruments, stringent and time-consuming regulatory policies for hematology analyzers and hematology product recalls are some restraints that might hinder the growth of the hematology market.

Rising number of advanced clinics in Asia Pacific is contributing to the growth of the hematology market in this region

Regional segmentation of global hematology market by Coherent Market Insights comprises of North America, Latin America, Europe, Africa, Asia Pacific, and The Middle East. The availability of a large number of diagnostic centers and the adoption of highly adopted hematology analyzers by the laboratories is owing to the domination of North America in the hematology market. Rising population with blood disorders and investments made in research and development are some of the important factors for North America to hold the largest share in the hematology market.

The Asia Pacific is also expected to drive growth in the hematology market followed by North America and Europe. Growing patient population, rising demand for technologically advanced medical devices, and a rise in a number of advanced clinics are some of the driving factors of hematology market in this region.

Hematology Market-Competitive landscape

Key business players operating the global hematology market include Abbott Laboratories, Sysmex Co., Beckman Coulter, Danaher, Mind ray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio Rad laboratories, and Sigma Aldrich Co.  Companies are even adopting the strategy of merger and acquisition to sustain in the global hematology market.

Key Development

  • In November 2017, Sysmex Corporation received a CLIA-waiver certification under the US regulatory approval system for the XW-100 automated hematology analyzer.
  • In March 2018, Roche announced that its new hematology testing solution, the cobas m 511 integrated hematology analyzer, received 510(k) clearance from the U.S. FDA.
  • In January 2018, Abbott, received CE Mark for its Alinity h-series integrated system for hematology testing. The new Alinity h-series solution integrates the Alinity hq with the Alinity hs slide maker and stainer module into a combined solution.
  • In October 2017, HORIBA Medical and Siemens Healthineers entered into long term agreement to combine the complementary innovative technology offerings of each company to address the multidisciplinary requirements of In-vitro diagnostics testing and hematology technology solution.
  • In May 2017, Horiba medical developed a new Yumizen H550 hematology diagnostic solution, which is a compact six-part differential hematology analyzer with an auto sampling system which aims at providing a full walk-away capability to a variety of clinical environments

Hematology Market-Taxonomy

The global hematology market is segmented by products, by applications, by end -users and by region

By Product

  • Hematology analyzers
  • Flow cytometers
  • Cell counters
  • Slide strainers
  • Coagulation analyzers
  • Hematology testing
  • Centrifuges
  • HemoglobinometersDD
  • Others

By Application

  • Infectious diseases
  • Blood screening
  • Diabetes
  • HIV
  • Cancer
  • Cardiovascular diseases
  • Others

By End User

  • Diagnostic laboratories
  • Hospitals
  • Clinics
  • Research and development centers
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.